Here's Why You Should Retain Glaukos Stock in Your Portfolio Now [Yahoo! Finance]
Glaukos Corporation (GKOS)
Last glaukos corporation earnings: 2/27 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.glaukos.com/investors/investor-overview/default.aspx
Company Research
Source: Yahoo! Finance
Shares of this Zacks Rank #3 (Hold) company have gained 12.5% so far this year compared with the industry's 7.9% growth. The S&P 500 Index has increased 14.4% in the same time frame. Glaukos, with a market capitalization of $6.67 billion, is a leading ophthalmic medical technology and pharmaceutical company. The company has a trailing four-quarter average earnings surprise of 22.19%. Image Source: Zacks Investment Research Rapid iDose TR Adoption: iDose TR is emerging as Glaukos' most powerful growth driver, with approximately $40 million in third-quarter 2025 revenues and strong physician uptake. Management emphasized robust clinical data, including multiple Phase III trials and peer-reviewed publications, supporting its use as a long-duration pharmaceutical alternative to topical drops. Importantly, iDose adoption is expanding beyond early adopter MAC regions, with increasing use in both standalone and combination cataract procedures. As reimbursement stabilizes and remaini
Show less
Read more
Impact Snapshot
Event Time:
GKOS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GKOS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GKOS alerts
High impacting Glaukos Corporation news events
Weekly update
A roundup of the hottest topics
GKOS
News
- Glaukos (NYSE:GKOS) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..MarketBeat
- Glaukos Corporation (NYSE:GKOS): Are Analysts Optimistic? [Yahoo! Finance]Yahoo! Finance
- Glaukos price target raised to $145 from $115 at Stephens [Yahoo! Finance]Yahoo! Finance
- Glaukos (NYSE:GKOS) had its "overweight" rating reaffirmed by analysts at Stephens.MarketBeat
- Glaukos (NYSE:GKOS) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $116.00 price target on the stock.MarketBeat
GKOS
Earnings
- 10/29/25 - Beat
GKOS
Sec Filings
- 1/8/26 - Form 144
- 1/7/26 - Form 4
- 1/7/26 - Form 4
- GKOS's page on the SEC website